SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-20-000034
Filing Date
2020-11-04
Accepted
2020-11-04 16:15:55
Documents
83
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 2080186
2 ex31-1.htm EX-31.1 17276
3 ex31-2.htm EX-31.2 17436
4 ex32-1.htm EX-32.1 8812
  Complete submission text file 0001641172-20-000034.txt   10002985

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lctx-20200930.xsd EX-101.SCH 78892
6 XBRL CALCULATION FILE lctx-20200930_cal.xml EX-101.CAL 79801
7 XBRL DEFINITION FILE lctx-20200930_def.xml EX-101.DEF 350589
8 XBRL LABEL FILE lctx-20200930_lab.xml EX-101.LAB 566949
9 XBRL PRESENTATION FILE lctx-20200930_pre.xml EX-101.PRE 459397
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1940034
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 201286887
SIC: 2836 Biological Products, (No Diagnostic Substances)